Literature DB >> 30843186

Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN).

Jasper H A van Miert1,2, Hilde A M Kooistra1,2, Nic J G M Veeger3, Annelies Westerterp2, Margriet Piersma-Wichers1,2, Karina Meijer1.   

Abstract

Entities:  

Keywords:  anticoagulants; anticoagulation; drugs; thrombosis

Mesh：

Substances：

Year:  2019        PMID： 30843186     DOI： 10.1111/bjh.15856

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta-analysis.

Authors:  Maja Hellfritzsch; Kasper Adelborg; Per Damkier; Søren Paaske Johnsen; Jesper Hallas; Anton Pottegård; Erik Lerkevang Grove
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-06-25       Impact factor: 4.080

2.  Self-reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants.

Authors:  Myrthe M A Toorop; Nienke van Rein; Melchior C Nierman; Helga W Vermaas; Menno V Huisman; Felix J M van der Meer; Suzanne C Cannegieter; Willem M Lijfering
Journal:  Res Pract Thromb Haemost       Date:  2020-03-14

3.  Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?

Authors:  Jasper H A van Miert; Nic J G M Veeger; Karina Meijer
Journal:  Res Pract Thromb Haemost       Date:  2020-03-30

4.  Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Authors:  Linda P T Joosten; Sander van Doorn; Arno W Hoes; Melchior C Nierman; Nynke M Wiersma; Huiberdina L Koek; Martin E W Hemels; Menno V Huisman; Kit C Roes; Rutger M van den Bor; Wim F Buding; Frans H Rutten; Geert-Jan Geersing
Journal:  BMJ Open       Date:  2019-12-29       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.